I agree that this site is using cookies. You can find further informations here.
X
Toner, Keri
26  results:
Search for persons X
?
1

Durable immunity to EBV after rituximab and third-party LMP..:

Wistinghausen, Birte ; Toner, Keri ; Barkauskas, Donald A....
Blood Advances.  8 (2024)  5 - p. 1116-1127 , 2024
Link: https://doi.org/10.1182/..
 
?
2

Real-world use of tisagenlecleucel in children and young ad..:

Bender, Jonathan D ; Damodharan, Sudarshawn ; Capitini, Christian M...
Blood Advances.  , 2024
Link: https://doi.org/10.1182/..
 
?
3

Pediatric cutaneous T‐cell neoplasm and mimics with gamma‐d..:

Cheng, Jinjun ; Toner, Keri ; Habeshian, Kaiane...
Pediatric Blood & Cancer.  71 (2024)  3 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
4

Pediatric monomorphic post‐transplant lymphoproliferative d..:

Cheng, Jinjun ; Harney, Sarah ; Toner, Keri...
Pediatric Blood & Cancer.  71 (2024)  8 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
5

Hospital Resource Utilization in the First 100 Days after A..:

Alicea Marrero, Minelys M ; Vijapurapu, Sandhya ; Bushnell, Kathryn...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S238-S239 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Mediport Use As an Acceptable Standard for CAR T Cell Infus..:

Eylon, Maya ; Baggott, Christina ; Prabhu, Snehit...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S195-S196 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Mediport use as an acceptable standard for CAR T cell infus..:

Eylon, Maya ; Prabhu, Snehit ; John, Samuel...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
8

Mixed‐phenotype acute leukemia with BCL11B copy gain: What ..:

Toner, Keri ; Schore, Reuven ; Cheng, Jinjun
Pediatric Blood & Cancer.  70 (2023)  9 - p. , 2023
Link: https://doi.org/10.1002/..
 
?
9

Diagnosis and management of post-transplant lymphoprolifera..:

Rubinstein, Jeremy ; Toner, Keri ; Gross, Thomas.
Best Practice & Research Clinical Haematology.  36 (2023)  1 - p. 101446 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Overcoming barriers to drug development and enrollment in c..:

Toner, Keri ; Allen, Carl E. ; Jain, Shweta...
eJHaem.  4 (2023)  4 - p. 921-926 , 2023
Link: https://doi.org/10.1002/..
 
?
11

REFRACTORY B-LYMPHOBLASTIC LYMPHOMA SUCCESSFULLY TREATED WI..:

Dreyzin, A. ; Toner, Keri ; Wyche, E....
Leukemia Research.  121 (2022)  - p. S70 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Tumor-associated antigen–specific T cells with nivolumab ar..:

Dave, Hema ; Terpilowski, Madeline ; Mai, Mimi...
Blood Advances.  6 (2022)  2 - p. 473-485 , 2022
Link: https://doi.org/10.1182/..
 
?
13

Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted..:

Raskin, Scott ; Van Pelt, Stacey ; Toner, Keri...
Molecular Therapy - Methods & Clinical Development.  23 (2021)  - p. 296-306 , 2021
Link: https://doi.org/10.1016/..
 
?
14

T-cell therapies for T-cell lymphoma:

Toner, Keri ; Bollard, Catherine M. ; Dave, Hema
Cytotherapy.  21 (2019)  9 - p. 935-942 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Children With Medical Complexity: A Web-Based Multimedia Cu..:

Shah, Neha H. ; Bhansali, Priti ; Barber, Aisha...
Academic Pediatrics.  18 (2018)  1 - p. 79-85 , 2018
Link: https://doi.org/10.1016/..
 
1-15